Endoscopic Chemocauterization with Trichloroacetic Acid for Congenital or Recurrent Tracheoesophageal Fistula in Children with Esophageal Atresia: Experience from a Tertiary Center
Topic overview
This study evaluates endoscopic chemocauterization using trichloroacetic acid as a minimally invasive treatment option for recurrent and congenital tracheoesophageal fistulas in children with esophageal atresia. The approach offers a less invasive alternative to surgical re-intervention for managing this 3-10% postoperative complication.
Key takeaways
- Recurrent tracheoesophageal fistula occurs in 3-10% of patients after esophageal atresia repair
- Endoscopic chemocauterization with trichloroacetic acid offers a minimally invasive treatment option for recurrent TEF
- TCA chemocauterization can be effective for both recurrent and congenital tracheoesophageal fistulas
- Endoscopic management avoids repeat thoracotomy and associated surgical morbidity in pediatric patients
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Endoscopic Chemocauterization with Trichloroacetic Acid for Congenital or Recurrent Tracheoesophageal Fistula in Children with Esophageal Atresia: Experience from a Tertiary Center. GlobalCastMD Medical Library. 2023-10-27. https://library.globalcastmd.com/article/8322
Comments